Loading...
Loading...
Browse all stories on DeepNewz
VisitEli Lilly Announces $5.3 Billion Investment in Indiana to Expand Drug Manufacturing by 2028
May 24, 2024, 06:42 PM
Eli Lilly announced a $5.3 billion investment to expand manufacturing for its drugs Mounjaro and Zepbound in Indiana. The new facility, which is expected to be operational by 2028, will be the largest site in the U.S. for active pharmaceutical ingredients, according to CEO David Ricks. This investment is part of Eli Lilly's strategy to meet growing demand and capitalize on the expanding market for health-related products. Bank of America has high revenue expectations for Eli Lilly's upcoming drug launches, which Ricks believes are achievable given the current market dynamics.
View original story
Markets
No • 50%
Yes • 50%
Press releases from Eli Lilly or local Indiana news reports
No • 50%
Yes • 50%
FDA announcements or press releases from Eli Lilly
Yes • 50%
No • 50%
FDA announcements or press releases from Eli Lilly
Delayed by more than 1 year • 33%
Completed on schedule • 33%
Delayed by up to 1 year • 33%
Press releases from Eli Lilly or local Indiana news reports
Below 10% • 25%
15% to 20% • 25%
Above 20% • 25%
10% to 15% • 25%
Industry reports on pharmaceutical market share
Above $2 billion • 25%
$1 billion to $2 billion • 25%
$500 million to $1 billion • 25%
Below $500 million • 25%
Financial earnings reports from Eli Lilly